Showing results (221-230 of 887) with videos related to

Sort By:
Pageof 89
European Journal of Clinical Investigation|January 4, 2012
Lipoprotein-associated phospholipase A2 and outcome in patients with type 2 diabetes on haemodialysisKarl Winkler, Michael M Hoffmann, Vera Krane, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 3, 2008
Antiproteinuric effects of angiotensin receptor blockers: telmisartan versus valsartan in hypertensive patients with type 2 diabetes mellitus and overt nephropathyJan Galle, Edzard Schwedhelm, Sabine Pinnetti, et al.
Lancet (London, England)|November 28, 2025
Chronic kidney diseaseWilliam G Herrington, Parminder K Judge, Morgan E Grams, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 29, 2004
Effect of dialysis flux and membrane material on dyslipidaemia and inflammation in haemodialysis patientsChristoph Wanner, Udo Bahner, Renate Mattern, et al.
Atherosclerosis|August 30, 2011
Lack of association between the Trp719Arg polymorphism in kinesin-like protein-6 and cardiovascular risk and efficacy of atorvastatin among subjects with diabetes on dialysis: the 4D studyMichael M Hoffmann, Winfried März, Bernd Genser, et al.
Annual Review of Medicine|November 25, 2010
The Fabry cardiomyopathy: models for the cardiologistFrank Weidemann, Markus Niemann, David G Warnock, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 12, 2019
Major adverse renal events (MARE): a proposal to unify renal endpointsFriedrich C Prischl, Peter Rossing, George Bakris, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|October 17, 2024
Adverse Impacts of PEGylated Protein Therapeutics: A Targeted Literature ReviewChae Sung Lee, Yogesh Kulkarni, Vicki Pierre, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 1, 2002
Combination treatment with an ET(A)-receptor blocker and an ACE inhibitor is not superior to the respective monotherapies in attenuating chronic transplant nephropathy in a 'Fisher-to-Lewis' rat modelJudith Adams, Giulio Odoni, Hiroaki Ogata, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|February 16, 2007
Frequency of albuminuria in primary care: a cross-sectional studyPeter Bramlage, David Pittrow, Hendrik Lehnert, et al.
Pageof 89